InvestorsHub Logo
Followers 38
Posts 9486
Boards Moderated 0
Alias Born 05/12/2006

Re: rocalinda post# 277502

Wednesday, 10/21/2020 6:53:05 AM

Wednesday, October 21, 2020 6:53:05 AM

Post# of 457757
The math works out to $150 to $200 pps with the current share count if approved for AD based on AD drug valuation. That part isn't a guess. But anything higher is absolutely crazy until sure why $100 to $130 is a stretch. $20B market cap had been pretty much proven already buy market reaction and analyst projections for companies containing or shooting for AD drugs...accept for Anavex. Currently we would get to $125 pps at a $10B market cap. I have always set 10B as a realistic target after AD approval but before revenue reported.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News